This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: University of Ghent. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: Tom Coenye: Innovator in Pharmaceutical Applications
Introduction
Tom Coenye is a notable inventor based in Mariakerke, Belgium. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on hamamelitannin analogues. His research focuses on the development of compounds that can be utilized in both human and veterinary medicine.
Latest Patents
Tom Coenye holds a patent for "Hamamelitannin analogues and uses thereof." This invention relates to hamamelitannin analogues and pharmaceutical compositions that include these compounds. The patent emphasizes the use of these analogues in combination with anti-microbial agents, such as antibiotics or disinfectants. The primary application of these compounds is in the prevention and treatment of bacterial infections in both humans and animals.
Career Highlights
Coenye is affiliated with the University of Ghent, where he conducts his research and development activities. His work has garnered attention for its potential impact on medical treatments and the pharmaceutical industry. With a focus on innovative solutions, he continues to explore new avenues in the field of medicine.
Collaborations
Tom Coenye collaborates with esteemed colleagues, including Arno Vermote and Serge Van Calenbergh. These partnerships enhance the research efforts and contribute to the advancement of pharmaceutical applications.
Conclusion
In summary, Tom Coenye is a distinguished inventor whose work on hamamelitannin analogues has the potential to revolutionize treatments for bacterial infections. His contributions to the University of Ghent and collaborations with fellow researchers underscore his commitment to innovation in the pharmaceutical field.